Bristol-Myers Squibb Company (BMY) · page 56 of 197
Uses a 'patent cliff' metaphor to argue against the acquisition.
Activist deck · preempt_rebuttal · preempt_rebuttal · dense density
Slide locked Sign in to view
Slide schematic 7/7
callout 1/1 chart 1/1 quote 1/1 source-note 1/1 subtitle 1/1 title 2/2
Components 7
primary line pull-quote source-note subtitle action-title headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1